Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 20, 2017
Pharmacy Choice - News - Drug Delivery Systems - January 20, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 81     Next >>     Go To Page:

1/20/17 - $95.59 Billion Transdermal Drug Delivery Market Analysis & Trends - Technology, Application - Forecast to 2025
Research and Markets has announced the addition of the "Transdermal Drug Delivery Market Analysis& Trends- Technology, Application- Forecast to 2025" report to their offering. The Global Transdermal Drug Delivery Market is poised to grow at a CAGR of around 11.6% over the next decade to reach approximately $95.57 billion by 2025.. Depending on th
1/20/17 - A new direction in ophthalmic development: Nanoparticle drug delivery systems
By a News Reporter-Staff News Editor at Drug Week Most ophthalmic diseases are usually treated with topically administered drug formulations. Their main disadvantage is the short time of contact with the eye, which leads to a low degree of absorption of the active substance. This requires frequent instillation, which usually leads to a high syste
1/20/17 - Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA [Tehran Times (Iran)]
-Adamis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration has accepted for review the Companys New Drug Application for its Epinephrine Pre-filled Syringe product candidate for the emergency treatment of anaphylaxis. Filed on December 15, 2016, the resubmission was intended to address the issues raised by the FD
1/20/17 - Advanced Drug Delivery Technology, Route Of Administration, End User Market Analysis & Trends 2016-2025: Increasing Demand for Generic Drugs and Biosimilars
Research and Markets has announced the addition of the "Advanced Drug Delivery Market Analysis& Trends- Technology, Route Of Administration, End User- Forecast to 2025" report to their offering. The Global Advanced Drug Delivery Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $330.70 billion by 2025..
1/20/17 - Aurobindo Receives FDA Approval for Ziprasidone HCl Capsules, 20 mg, 40 mg, 60 mg and 80 mg
Release date- 19012017- East Windsor, N.J.- Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for Ziprasidone HCl Capsules, 20 mg, 40 mg, 60 mg and 80 mg. The Division of Bioequivalence has determined Aurobindo Pharma Limited's Ziprasidone HCl Capsules, 20 mg, 40 mg, 60 mg and 80 mg to be bioequivalent
1/20/17 - Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with HER3-Positive Metastatic or Unresectable Breast Cancer
Release date- 19012017- Tokyo, Japan and Parsippany, N.J.- Daiichi Sankyo Company, Limited announced today the initiation of a three-part open-label phase 1/ 2 study in Japan with U3-1402, a novel HER3-targeting antibody drug conjugate, in patients with HER3-positive metastatic or unresectable breast cancer who are refractory or intolerant to stand
1/20/17 - European Medicines Agency Validates Gilead's Marketing Authorization Application for Investigational Chronic Hepatitis C Therapy Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX)
Gilead Sciences, Inc. today announced that the company s Marketing Authorization Application for the investigational, once-daily, single tablet regimen of sofosbuvir 400 mg, velpatasvir 100 mg and voxilaprevir 100 mg for the treatment of chronic hepatitis C virus- infected patients has been fully validated and is now under assessment by the Euro
1/20/17 - FDA Grants Bayer Priority Review for Stivarga regorafenib for the Second-Line Systemic Treatment of Liver Cancer
By a News Reporter-Staff News Editor at Drug Week- Bayer announced that the U.S. Food and Drug Administration has granted priority review status for the supplemental New Drug Application for Stivarga tablets for the second-line systemic treatment of patients with hepatocellular carcinoma in the U.S. The FDA grants priority review to medicines
1/20/17 - Global Drug Delivery Technologies Market Analysis & Trends Report 2016 - Industry Forecast to 2025 for the $2.22 Billion Market [Namibian Sun]
-Research and Markets has announced the addition of the "Global Drug Delivery Technologies Market Analysis& Trends- Industry Forecast to 2025" report to their offering. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. With comprehensive m
1/20/17 - Innovative Strategies for the Development of Lipid-based Oral Medicines to be Presented by Catalent and Gattefoss at Forthcoming Workshop [Tehran Times (Iran)]
The one day event is to be held at the San Mateo Marriott San Francisco Airport Hotel, San Mateo, Calif., on Thursday, Feb. 2. The workshop will include scientific presentations and case studies from Catalent, Wollowitz Associates and Gattefoss, and is designed for drug development scientists to expand their oral drug delivery toolkit using lipid f
1/20/17 - Lannett Announces Approval For Lopinavir And Ritonavir Oral Solution USP, 80 Mg/20 Mg Per mL
By a News Reporter-Staff News Editor at Drug Week- Lannett Company, Inc. announced that it received approval last week from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Lopinavir and Ritonavir Oral Solution USP, 80 mg/20 mg per mL, the therapeutic equivalent to the reference listed drug, Kaletra Oral Soluti
1/20/17 - New Drug Delivery Systems Findings from K. Sydow et al Outlined (Lipopeptide-based micellar and liposomal carriers: Influence of surface charge and...
New Drug Delivery Systems Findings from K. Sydow et al Outlined. By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting from Berlin, Germany, by NewsRx journalists, research stated, "Lipopeptide-based micelles and liposomes were found to differ
1/20/17 - New Drug Delivery Systems Findings from Southwest University Outlined [Conjugation of Lectin to Poly(epsilon-caprolactone)-block-glycopolymer...
By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Drug Delivery Systems have been presented. According to news reporting originating in Chongqing, People's Republic of China, by NewsRx journalists, research stated, "Amphiphilic poly- block-poly block copolymers were synthesized via a combination of ring-openi
1/20/17 - New Drug Delivery Systems Study Findings Recently Were Reported by Researchers at School of Materials Science (Lateral Diffusion of a Submicrometer...
New Drug Delivery Systems Study Findings Recently Were Reported by Researchers at School of Materials Science. Our news journalists obtained a quote from the research from the School of Materials Science, "However, the motion of small particles of. Our news journalists report that additional information may be obtained by contacting K. Shigyou, Jap
1/20/17 - Patent Issued for Assembly for a Drug Delivery Device and Piston Rod (USPTO 9533104)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Raab, Steffen; Arnhold, Sandra, filed on November 11, 2011, was published online on January 3, 2017. The assignee for this patent, patent number 9533104, is Sanofi-Aventis Deutshclan
1/20/17 - Patent Issued for Dose Setting Mechanism for Priming a Drug Delivery Device (USPTO 9533100)
By a News Reporter-Staff News Editor at Drug Week Sanofi-Aventis Deutschland GmbH has been issued patent number 9533100, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventor is Jones, Christopher. This patent was filed on May 28, 2010 and was published online on January 3, 2017.
1/20/17 - Patent Issued for Drive Mechanisms Suitable for Use in Drug Delivery Devices (USPTO 9533105)
By a News Reporter-Staff News Editor at Drug Week Sanofi-Aventis Deutschland GmbH has been issued patent number 9533105, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Veasey, Robert Frederick; Perkins, Robert; Plumptre, David Aubrey. This patent was filed on June 30, 2014 and wa
1/20/17 - Recent Findings from University of California School of Medicine Advance Knowledge in Drug Delivery Systems (A review of nebulized drug delivery in...
Recent Findings from University of California School of Medicine Advance Knowledge in Drug Delivery Systems. Our news journalists report that additional information may be obtained by contacting D.P. Tashkin, Dept. of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States. Keywords for this news article include: Californi
1/20/17 - Reports on Drug Delivery Systems Findings from Donghua University Provide New Insights (Multifunctional Redox-Responsive Mesoporous Silica...
In the current study, we fabricated a new multifunctional drug delivery system based on MSN capped by gadolinium-based bovine serum albumin complex and hyaluronic acid via reductive-cleavable disulfide bond. " Our news journalists obtained a quote from the research from Donghua University, "In this multifunctional nanoparticle, BSA-Gd component was
1/20/17 - Reports Outline Drug Delivery Systems Study Findings from Department of Chemical Engineering (Applications of Polymers as Pharmaceutical Excipients...
Reports Outline Drug Delivery Systems Study Findings from Department of Chemical Engineering. According to news reporting out of Ramat Gan, Israel, by NewsRx editors, research stated, "Over the last few decades, polymers have been extensively used as pharmaceutical excipients in drug delivery systems. Our news journalists obtained a quote from the
1/20/17 - Reports Outline Drug Delivery Systems Study Findings from Wenzhou Medical University (Mesoporous silica nanoparticles for stimuli-responsive...
According to news originating from Zhejiang, People's Republic of China, by NewsRx correspondents, research stated, "With the development of nanotechnology, the application of nanomaterials in the field of drug delivery has attracted much attention in the past decades. For more information on this research see: Mesoporous silica nanoparticles for..
1/20/17 - Researchers at Chinese Academy of Medical Sciences Report New Data on Drug Delivery Systems (Folic acid-targeted disulfide-based cross-linking...
Researchers at Chinese Academy of Medical Sciences Report New Data on Drug Delivery Systems. By a News Reporter-Staff News Editor at Drug Week New research on Drugs and Therapies- Drug Delivery Systems is the subject of a report. According to news reporting originating from Tianjin, People's Republic of China, by NewsRx correspondents, research s
1/20/17 - Researchers from University of Lisbon Detail New Studies and Findings in the Area of Drug Delivery Systems (Diffusion-Based Design of Multi-Layered...
Researchers from University of Lisbon Detail New Studies and Findings in the Area of Drug Delivery Systems. According to news originating from Lisbon, Portugal, by NewsRx correspondents, research stated, "The study of ocular drug delivery systems has been one of the most covered topics in drug delivery research. The news correspondents report that
1/20/17 - Richmond-based Kalo's injector returning to markets in February Richmond-based Kaleo's Auvi-Q epinephrine injector returning to market Feb. 14 X
Richmond-based pharmaceutical company Kalo is bringing its Auvi-Q epinephrine auto-injector for treating severe allergic reactions back to the market Feb. 14, the company announced Thursday. The company also announced a new Auvi-Q AffordAbility program for the product, which will carry a list price of $4,500 for two single-use auto-injectors and
1/20/17 - Study Data from Donghua University Update Understanding of Drug Delivery Systems (Multifunctional Redox-Responsive Mesoporous Silica Nanoparticles...
In the current study, we fabricated a new multifunctional drug delivery system based on MSN capped by gadolinium based bovine serum albumin complex and hyaluronic acid via reductive-cleavable disulfide bond. " The news reporters obtained a quote from the research from Donghua University, "In this multifunctional nanoparticle, BSA-Gd component was..
Articles(s): 1 - 25 of 81     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415